Beneficiary Access to Care Act of 2003

The Beneficiary Access to Care Act of 2003 was designed to adjust how Medicare compensates hospitals for outpatient services, specifically focusing on the costs of prescription drugs and biological treatments. The bill sought to ensure that certain high-cost medications, including those used in cancer therapy, remained financially accessible to patients by requiring Medicare to categorize and pay for them as separate service groups rather than bundling them into general hospital fees. Additionally, it mandated a federal study to evaluate the costs associated with hospital pharmacy services to ensure that reimbursement rates accurately reflected the expenses of providing specialized care.